Grant: Operating Grant
McMaster University
$154,915.00
Development and feasibility testing of decision support for patients who are candidates for an implantable defibrillator
EF 2011-12
Résumé
In Canada, sudden cardiac death from an abnormal heart rhythm is an important cause of death. A medical device called the implantable cardioverter defibrillator (ICD), offers people who may be at risk of having an abnormal rhythm, a treatment option. The ICD can detect an abnormal rhythm and correct it by delivering an internal shock through a wire attached to the heart. The ICD also has an option for an extra wire that can help the heart pump more effectively in patients with heart failure. Patients visit a heart specialist to see if an ICD for prevention is appropriate (this is for someone who has never experienced an abnormal rhythm). In deciding to accept or decline the ICD, patients must carefully balance the benefits and risks alongside other health problems they may have. Some patients may have complications, and others may not adjust well if they receive shocks from the ICD. In Canada, there is no clear framework to guide patients to understand the risks/benefits of ICD options. Decision support, using a decision aid, can help prepare patients to make informed treatment decisions. When decision aids are used in other health treatment situations, patients report better knowledge about benefits, risks, less uncertainty, and in fewer decision delays. This research seeks to develop decision support for patients who are considering ICD treatment options. The project has three phases: 1) guided by panel of experts, we will combine research and practice guidelines to gather risk/benefit information. Writing and revising of the decision aid will follow, 2) field-testing of the decision aid in ICD patients, and 3) testing the feasibility of conducting a trial to evaluate the effectiveness of the decision aid on decision quality in new ICD candidates.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
239508
Name
Carroll Sandra L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
Knowledge Mobilization Science
Projecttitle
Development and feasibility testing of decision support for patients who are candidates for an implantable defibrillator
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$154,915
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Decision Aids; Feasibility Testing; Implantable Cardioverter Defibrillator; Knowledge Translation; Patient Participation
Abstract
In Canada, sudden cardiac death from an abnormal heart rhythm is an important cause of death. A medical device called the implantable cardioverter defibrillator (ICD), offers people who may be at risk of having an abnormal rhythm, a treatment option. The ICD can detect an abnormal rhythm and correct it by delivering an internal shock through a wire attached to the heart. The ICD also has an option for an extra wire that can help the heart pump more effectively in patients with heart failure. Patients visit a heart specialist to see if an ICD for prevention is appropriate (this is for someone who has never experienced an abnormal rhythm). In deciding to accept or decline the ICD, patients must carefully balance the benefits and risks alongside other health problems they may have. Some patients may have complications, and others may not adjust well if they receive shocks from the ICD. In Canada, there is no clear framework to guide patients to understand the risks/benefits of ICD options. Decision support, using a decision aid, can help prepare patients to make informed treatment decisions. When decision aids are used in other health treatment situations, patients report better knowledge about benefits, risks, less uncertainty, and in fewer decision delays. This research seeks to develop decision support for patients who are considering ICD treatment options. The project has three phases: 1) guided by panel of experts, we will combine research and practice guidelines to gather risk/benefit information. Writing and revising of the decision aid will follow, 2) field-testing of the decision aid in ICD patients, and 3) testing the feasibility of conducting a trial to evaluate the effectiveness of the decision aid on decision quality in new ICD candidates.
Competitiondate
201109
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Carroll, Sandra L
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $154,915~ $0~